vai alle Pubblicazioni
Pubblicazioni antecedenti il 2004
Pubblicazioni a stampa su riviste internazionali con Impact
Factor
1: Visani G, Sapienza MR, Isidori A, Tripodo C, Laginestra MA,
Righi S, Sagramoso
Sacchetti CA, Gazzola A, Mannu C, Rossi M, De Nictolis M, Valentini
M, Donati M,
Emiliani R, Alesiani F, Paolini S, Finelli C, Pileri SA, Piccaluga
PP. SNPs Array
Karyotyping Reveals a Novel Recurrent 20p13 Amplification in
Primary
Myelofibrosis. PLoS One. 2011;6(11):e27560. Epub 2011 Nov 14.
PubMed PMID:
22110671; PubMed Central PMCID: PMC3215741.
2: Pileri SA, Agostinelli C, Bacci F, Sabattini E, Sagramoso C,
Falini B,
Piccaluga PP. Pathobiology of ALK-negative anaplastic large cell
lymphoma.
Pediatr Rep. 2011 Jun 22;3 Suppl 2:e5. PubMed PMID: 22053281;
PubMed Central
PMCID: PMC3206530.
3: Agostinelli C, Hartmann S, Klapper W, Korkolopoulou P, Righi S,
Marafioti T,
Piccaluga PP, Patsouris E, Hansmann ML, Lennert K, Pileri SA.
Peripheral T cell
lymphomas with follicular T helper phenotype: a new basket or a
distinct entity?
Revising Karl Lennert's personal archive. Histopathology. 2011
Oct;59(4):679-91.
doi: 10.1111/j.1365-2559.2011.03981.x. PubMed PMID: 22014049.
4: Ciccone M, Agostinelli C, Rigolin GM, Piccaluga PP, Cavazzini F,
Righi S,
Sista MT, Sofritti O, Rizzotto L, Sabattini E, Fioritoni G, Falorio
S, Stelitano
C, Olivieri A, Attolico I, Brugiatelli M, Zinzani PL, Saccenti E,
Capello D,
Negrini M, Cuneo A, Pileri S. Proliferation centers in chronic
lymphocytic
leukemia: correlation with cytogenetic and clinicobiological
features in
consecutive patients analyzed on tissue microarrays. Leukemia. 2011
Sep 23. doi:
10.1038/leu.2011.247. [Epub ahead of print] PubMed PMID:
21941366.
5: Roncolato F, Gazzola A, Zinzani PL, Pileri SA, Piccaluga PP.
Targeted
molecular therapy in peripheral T-cell lymphomas. Expert Rev
Hematol. 2011
Oct;4(5):551-62. PubMed PMID: 21939422.
6: Piccaluga PP, Gazzola A, Agostinelli C, Bacci F, Sabattini E,
Pileri SA.
Pathobiology of Epstein-Barr virus-driven peripheral T-cell
lymphomas. Semin
Diagn Pathol. 2011 Aug;28(3):234-44. Review. PubMed PMID:
21850988.
7: Pileri A Jr, Patrizi A, Agostinelli C, Neri I, Sabattini E,
Bacci F, Piccaluga
PP, Pimpinelli N, Pileri SA. Primary cutaneous lymphomas: a
reprisal. Semin Diagn
Pathol. 2011 Aug;28(3):214-33. Review. PubMed PMID: 21850987.
8: Inghirami G, Pileri SA; European T-Cell Lymphoma Study Group.
Anaplastic
large-cell lymphoma. Semin Diagn Pathol. 2011 Aug;28(3):190-201.
Review. PubMed
PMID: 21850985.
9: Paolini S, Gazzola A, Sabattini E, Bacci F, Pileri S, Piccaluga
PP.
Pathobiology of acute lymphoblastic leukemia. Semin Diagn Pathol.
2011
May;28(2):124-34. Review. PubMed PMID: 21842698.
10: Pileri SA, Agostinelli C, Sabattini E, Bacci F, Sagramoso C,
Pileri A Jr,
Falini B, Piccaluga PP. Lymphoma classification: the quiet after
the storm. Semin
Diagn Pathol. 2011 May;28(2):113-23. Review. PubMed PMID:
21842697.
11: Gazzola A, Sabattini E, Mannu C, Bacci F, Sagramoso Sacchetti
CA, Artioli P,
Chilli L, Da Pozzo G, Piccioli M, Falini B, Pileri SA, Piccaluga
PP. Partial
nodal involvement by marginal zone lymphoma. Use of IGK gene
rearrangement
analysis in diagnostic work-up. Pathologica. 2011 Feb;103(1):14-8.
PubMed PMID:
21837920.
12: Piccaluga PP, Agostinelli C, Tripodo C, Gazzola A, Bacci F,
Sabattini E,
Pileri SA; European T‑cell Lymphoma Study Group. Peripheral T-cell
lymphoma
classification: the matter of cellular derivation. Expert Rev
Hematol. 2011
Aug;4(4):415-25. Review. PubMed PMID: 21801133.
13: Zinzani PL, Piccaluga PP. Primary mediastinal DLBCL: evolving
biologic
understanding and therapeutic strategies. Curr Oncol Rep. 2011
Oct;13(5):407-15.
doi: 10.1007/s11912-011-0189-5. Review. PubMed PMID:
21789543.
14: Piccaluga PP, Pileri SA, Agostinelli C, Klapper W, Lennert K.
Follicular
lymphoma: still Six characters in search of an author? Leuk
Lymphoma. 2011
Sep;52(9):1655-67. Epub 2011 Jun 10. Review. PubMed PMID:
21657965.
15: Tabanelli V, Agostinelli C, Sabattini E, Gazzola A, Bacci F,
Capria S, Mannu
C, Righi S, Sista MT, Meloni G, Pileri SA, Piccaluga PP.
Systemic
Epstein-Barr-virus-positive T cell lymphoproliferative childhood
disease in a
22-year-old Caucasian man: A case report and review of the
literature. J Med Case
Reports. 2011 Jun 7;5:218. PubMed PMID: 21649898; PubMed Central
PMCID:
PMC3130681.
16: Barreca A, Lasorsa E, Riera L, Machiorlatti R, Piva R, Ponzoni
M, Kwee I,
Bertoni F, Piccaluga PP, Pileri SA, Inghirami G; European T-Cell
Lymphoma Study
Group. Anaplastic lymphoma kinase in human cancer. J Mol
Endocrinol. 2011 Jul
4;47(1):R11-23. Print 2011. Review. PubMed PMID: 21502284.
17: Tripodo C, Sangaletti S, Piccaluga PP, Prakash S, Franco G,
Borrello I, Orazi
A, Colombo MP, Pileri SA. The bone marrow stroma in hematological
neoplasms--a
guilty bystander. Nat Rev Clin Oncol. 2011 Mar 29;8(8):456-66.
doi:
10.1038/nrclinonc.2011.31. Review. PubMed PMID: 21448151.
18: Piccaluga PP, Gazzola A, Mannu C, Agostinelli C, Bacci F,
Sabattini E,
Sagramoso C, Piva R, Roncolato F, Inghirami G, Pileri SA.
Pathobiology of
anaplastic large cell lymphoma. Adv Hematol. 2010:345053. Epub 2011
Feb 6. PubMed
PMID: 21331150; PubMed Central PMCID: PMC3038421.
19: Tumwine LK, Lalitha R, Agostinelli C, Luzige S, Orem J,
Piccaluga PP, Osuwat
LO, Pileri SA. Primary effusion lymphoma associated with Human
Herpes Virus-8 and
Epstein Barr virus in an HIV-infected woman from Kampala, Uganda: a
case report.
J Med Case Reports. 2011 Feb 14;5(1):60. PubMed PMID: 21320326;
PubMed Central
PMCID: PMC3048476.
20: Piccaluga PP, Agostinelli C, Gazzola A, Tripodo C, Bacci F,
Sabattini E,
Sista MT, Mannu C, Sapienza MR, Rossi M, Laginestra MA,
Sagramoso-Sacchetti CA,
Righi S, Pileri SA. Pathobiology of hodgkin lymphoma. Adv
Hematol.
2011;2011:920898. Epub 2010 Dec 22. PubMed PMID: 21253495; PubMed
Central PMCID:
PMC3021869.
21: Piccaluga PP, De Falco G, Kustagi M, Gazzola A, Agostinelli C,
Tripodo C,
Leucci E, Onnis A, Astolfi A, Sapienza MR, Bellan C, Lazzi S,
Tumwine L, Mawanda
M, Ogwang M, Calbi V, Formica S, Califano A, Pileri SA, Leoncini L.
Gene
expression analysis uncovers similarity and differences among
Burkitt lymphoma
subtypes. Blood. 2011 Mar 31;117(13):3596-608. Epub 2011 Jan 18.
PubMed PMID:
21245480.
22: Piccaluga PP, Sapienza MR, Agostinelli C, Sagramoso C, Mannu C,
Sabattini E,
Zinzani PL, Pileri SA. Biology and treatment of follicular
lymphoma. Expert Rev
Hematol. 2009 Oct;2(5):533-47. Review. PubMed PMID: 21083019.
23: Piccaluga PP, Arpinati M, Candoni A, Laterza C, Paolini S,
Gazzola A,
Sabattini E, Visani G, Pileri SA. Surface antigens analysis reveals
significant
expression of candidate targets for immunotherapy in adult acute
lymphoid
leukemia. Leuk Lymphoma. 2011 Feb;52(2):325-7. Epub 2010 Nov 15.
PubMed PMID:
21077738.
24: Visani G, Breccia M, Gozzini A, Specchia G, Montefusco E, Morra
E, Annunziata
M, Camera A, Cavazzini F, Stagno F, Pregno P, Usala E, Santini V,
Piccaluga PP,
Isidori A. Dasatinib, even at low doses, is an effective
second-line therapy for
chronic myeloid leukemia patients resistant or intolerant to
imatinib. Results
from a real life-based Italian multicenter retrospective study on
114 patients.
Am J Hematol. 2010 Dec;85(12):960-3. PubMed PMID: 21069865.
25: Gazzola A, Sista MT, Agostinelli C, Righi S, Sapienza MR, Mannu
C, Rossi M,
Bacci F, Sabattini E, Went P, Zinzani PL, Pileri SA, Piccaluga PP.
CDKN1B/p27
expression in peripheral T cell lymphoma not otherwise specified. J
Clin Pathol.
2011 Jan;64(1):83-7. Epub 2010 Nov 2. PubMed PMID: 21045237.
26: Agostinelli C, Sabattini E, Gjørret JO, Righi S, Rossi M,
Mancini M,
Piccaluga PP, Bacci F, Marafioti T, Bettini G, Falini B, Pileri
SA.
Characterization of a new monoclonal antibody against PAX5/BASP in
1525
paraffin-embedded human and animal tissue samples. Appl
Immunohistochem Mol
Morphol. 2010 Dec;18(6):561-72. PubMed PMID: 20697266.
27: Piccaluga PP, Agostinelli C, Gazzola A, Mannu C, Bacci F,
Sabattini E, Pileri
SA. Prognostic markers in peripheral T-cell lymphoma. Curr Hematol
Malig Rep.
2010 Oct;5(4):222-8. Review. Erratum in: Curr Hematol Malig Rep.
2010
Oct;5(4):239. PubMed PMID: 20690003; PubMed Central PMCID:
PMC2948168.
28: Tripodo C, Gri G, Piccaluga PP, Frossi B, Guarnotta C, Piconese
S, Franco G,
Vetri V, Pucillo CE, Florena AM, Colombo MP, Pileri SA. Mast cells
and Th17 cells
contribute to the lymphoma-associated pro-inflammatory
microenvironment of
angioimmunoblastic T-cell lymphoma. Am J Pathol. 2010
Aug;177(2):792-802. Epub
2010 Jul 1. PubMed PMID: 20595635; PubMed Central PMCID:
PMC2913370.
29: Pantaleo MA, Mishani E, Nanni C, Landuzzi L, Boschi S,
Nicoletti G, Dissoki
S, Paterini P, Piccaluga PP, Lodi F, Lollini PL, Fanti S, Biasco G.
Evaluation of
modified PEG-anilinoquinazoline derivatives as potential agents for
EGFR imaging
in cancer by small animal PET. Mol Imaging Biol. 2010
Dec;12(6):616-25. PubMed
PMID: 20379787; PubMed Central PMCID: PMC2978890.
30: Piva R, Agnelli L, Pellegrino E, Todoerti K, Grosso V, Tamagno
I, Fornari A,
Martinoglio B, Medico E, Zamò A, Facchetti F, Ponzoni M, Geissinger
E, Rosenwald
A, Müller-Hermelink HK, De Wolf-Peeters C, Piccaluga PP, Pileri S,
Neri A,
Inghirami G. Gene expression profiling uncovers molecular
classifiers for the
recognition of anaplastic large-cell lymphoma within peripheral
T-cell neoplasms.
J Clin Oncol. 2010 Mar 20;28(9):1583-90. Epub 2010 Feb 16. PubMed
PMID: 20159827.
31: Tumwine LK, Agostinelli C, Campidelli C, Othieno E, Wabinga H,
Righi S,
Falini B, Piccaluga PP, Byarugaba W, Pileri SA. Immunohistochemical
and other
prognostic factors in B cell non Hodgkin lymphoma patients,
Kampala, Uganda. BMC
Clin Pathol. 2009 Dec 16;9:11. PubMed PMID: 20003543; PubMed
Central PMCID:
PMC2805675.
32: Tripodo C, Iannitto E, Florena AM, Pucillo CE, Piccaluga PP,
Franco V, Pileri
SA. Gamma-delta T-cell lymphomas. Nat Rev Clin Oncol. 2009
Dec;6(12):707-17. Epub
2009 Nov 10. Review. PubMed PMID: 19901919.
33: Hartmann S, Gesk S, Scholtysik R, Kreuz M, Bug S, Vater I,
Döring C,
Cogliatti S, Parrens M, Merlio JP, Kwiecinska A, Porwit A,
Piccaluga PP, Pileri
S, Hoefler G, Küppers R, Siebert R, Hansmann ML. High resolution
SNP array
genomic profiling of peripheral T cell lymphomas, not otherwise
specified,
identifies a subgroup with chromosomal aberrations affecting the
REL locus. Br J
Haematol. 2010 Feb;148(3):402-12. Epub 2009 Oct 22. PubMed PMID:
19863542.
34: Giebel S, Stella-Holowiecka B, Krawczyk-Kulis M, Gökbuget N,
Hoelzer D,
Doubek M, Mayer J, Piatkowska-Jakubas B, Skotnicki AB, Dombret H,
Ribera JM,
Piccaluga PP, Czerw T, Kyrcz-Krzemien S, Holowiecki J; Study Group
for Adult ALL
of the European Leukemia Net. Status of minimal residual disease
determines
outcome of autologous hematopoietic SCT in adult ALL. Bone Marrow
Transplant.
2010 Jun;45(6):1095-101. Epub 2009 Oct 26. PubMed PMID:
19855438.
35: Iacobucci I, Lonetti A, Messa F, Ferrari A, Cilloni D, Soverini
S, Paoloni F,
Arruga F, Ottaviani E, Chiaretti S, Messina M, Vignetti M,
Papayannidis C, Vitale
A, Pane F, Piccaluga PP, Paolini S, Berton G, Baruzzi A, Saglio G,
Baccarani M,
Foà R, Martinelli G. Different isoforms of the B-cell mutator
activation-induced
cytidine deaminase are aberrantly expressed in BCR-ABL1-positive
acute
lymphoblastic leukemia patients. Leukemia. 2010 Jan;24(1):66-73.
Epub 2009 Sep
17. PubMed PMID: 19759560.
36: Iacobucci I, Storlazzi CT, Cilloni D, Lonetti A, Ottaviani E,
Soverini S,
Astolfi A, Chiaretti S, Vitale A, Messa F, Impera L, Baldazzi C,
D'Addabbo P,
Papayannidis C, Lonoce A, Colarossi S, Vignetti M, Piccaluga PP,
Paolini S, Russo
D, Pane F, Saglio G, Baccarani M, Foà R, Martinelli G.
Identification and
molecular characterization of recurrent genomic deletions on 7p12
in the IKZF1
gene in a large cohort of BCR-ABL1-positive acute lymphoblastic
leukemia
patients: on behalf of Gruppo Italiano Malattie Ematologiche
dell'Adulto Acute
Leukemia Working Party (GIMEMA AL WP). Blood. 2009 Sep
3;114(10):2159-67. Epub
2009 Jul 9. Erratum in: Blood. 2010 Sep 23;116(12):2196. PubMed
PMID: 19589926.
37: Gazzola A, Bertuzzi C, Agostinelli C, Righi S, Pileri SA,
Piccaluga PP.
Physiological PTEN expression in peripheral T-cell lymphoma not
otherwise
specified. Haematologica. 2009 Jul;94(7):1036-7. Epub 2009 Jun 8.
PubMed PMID:
19508975; PubMed Central PMCID: PMC2704320.
38: Martinelli G, Iacobucci I, Soverini S, Piccaluga PP, Cilloni D,
Pane F. New
mechanisms of resistance in Philadelphia chromosome acute
lymphoblastic leukemia.
Expert Rev Hematol. 2009 Jun;2(3):297-303. Review. PubMed PMID:
21082971.
39: Visani G, Piccaluga P, Malagola M, Isidori A. Efficacy of
dasatinib in
conjunction with alpha-interferon for the treatment of
imatinib-resistant and
dasatinib-resistant Ph+ acute lymphoblastic leukemia. Leukemia.
2009
Sep;23(9):1687-8. Epub 2009 May 7. PubMed PMID: 19421228.
40: Piccaluga PP, Sabattini E, Bacci F, Agostinelli C, Righi S,
Salmi F, Testoni
N, Paolini S, Castagnetti F, Martinelli G, Falini B, Pileri SA.
Cytoplasmic
mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid
leukaemia.
Leukemia. 2009 Jul;23(7):1370-1. Epub 2009 May 7. PubMed PMID:
19421226.
41: Iacobucci I, Lonetti A, Cilloni D, Messa F, Ferrari A, Zuntini
R, Ferrari S,
Ottaviani E, Arruga F, Paolini S, Papayannidis C, Piccaluga PP,
Soverini S,
Saglio G, Pane F, Baruzzi A, Vignetti M, Berton G, Vitale A,
Chiaretti S, Müschen
M, Foà R, Baccarani M, Martinelli G. Identification of different
Ikaros cDNA
transcripts in Philadelphia-positive adult acute lymphoblastic
leukemia by a
high-throughput capillary electrophoresis sizing method.
Haematologica. 2008
Dec;93(12):1814-21. Epub 2008 Oct 6. Erratum in: Haematologica.
2010
Jun;95(6):1033. PubMed PMID: 18838475.
42: Agostinelli C, Piccaluga PP, Went P, Rossi M, Gazzola A, Righi
S, Sista T,
Campidelli C, Zinzani PL, Falini B, Pileri SA. Peripheral T cell
lymphoma, not
otherwise specified: the stuff of genes, dreams and therapies. J
Clin Pathol.
2008 Nov;61(11):1160-7. Epub 2008 Aug 28. Review. PubMed PMID:
18755717; PubMed
Central PMCID: PMC2582342.
43: Iacobucci I, Lonetti A, Messa F, Cilloni D, Arruga F, Ottaviani
E, Paolini S,
Papayannidis C, Piccaluga PP, Giannoulia P, Soverini S, Amabile M,
Poerio A,
Saglio G, Pane F, Berton G, Baruzzi A, Vitale A, Chiaretti S,
Perini G, Foà R,
Baccarani M, Martinelli G. Expression of spliced oncogenic Ikaros
isoforms in
Philadelphia-positive acute lymphoblastic leukemia patients treated
with tyrosine
kinase inhibitors: implications for a new mechanism of resistance.
Blood. 2008
Nov 1;112(9):3847-55. Epub 2008 Jul 23. Erratum in: Blood. 2010
Sep
23;116(12):2196. PubMed PMID: 18650450.
44: Malagola M, Peli A, Damiani D, Candoni A, Tiribelli M,
Martinelli G,
Piccaluga PP, Paolini S, De Rosa F, Lauria F, Bocchia M, Gobbi M,
Pierri I,
Zaccaria A, Zuffa E, Mazza P, Priccolo G, Gugliotta L, Bonini A,
Visani G, Skert
C, Bergonzi C, Roccaro AM, Filì C, Fanin R, Baccarani M, Russo D.
Incidence of
bacterial and fungal infections in newly diagnosed acute myeloid
leukaemia
patients younger than 65 yr treated with induction regimens
including
fludarabine: retrospective analysis of 224 cases. Eur J Haematol.
2008
Nov;81(5):354-63. Epub 2008 Aug 19. PubMed PMID: 18637030.
45: Candoni A, Martinelli G, Toffoletti E, Chiarvesio A, Tiribelli
M, Malagola M,
Piccaluga PP, Michelutti A, Simeone E, Damiani D, Russo D, Fanin
R.
Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine,
idarubicin
(FLAI-GO) as induction therapy in CD33-positive AML patients
younger than 65
years. Leuk Res. 2008 Dec;32(12):1800-8. Epub 2008 Jul 14. PubMed
PMID: 18621416.
46: Visani G, Ferrara F, Alesiani F, Ronconi S, Catarini M, D'adamo
F, Guiducci
B, Bernardi D, Barulli S, Piccaluga P, Rocchi M, Isidori A. R-COMP
21 for frail
elderly patients with aggressive B-cell non-Hodgkin lymphoma: a
pilot study. Leuk
Lymphoma. 2008 Jun;49(6):1081-6. PubMed PMID: 18569635.
47: Piccaluga PP, Califano A, Klein U, Agostinelli C, Bellosillo B,
Gimeno E,
Serrano S, Solè F, Zang Y, Falini B, Zinzani PL, Pileri SA. Gene
expression
analysis provides a potential rationale for revising the
histological grading of
follicular lymphomas. Haematologica. 2008 Jul;93(7):1033-8. Epub
2008 May 19.
PubMed PMID: 18492688.
48: Zinzani PL, Tani M, Pulsoni A, Gobbi M, Perotti A, De Luca S,
Fabbri A,
Zaccaria A, Voso MT, Fattori P, Guardigni L, Ronconi S, Cabras MG,
Rigacci L, De
Renzo A, Marchi E, Stefoni V, Fina M, Pellegrini C, Musuraca G,
Derenzini E,
Pileri S, Fanti S, Piccaluga PP, Baccarani M. Fludarabine and
mitoxantrone
followed by yttrium-90 ibritumomab tiuxetan in previously untreated
patients with
follicular non-Hodgkin lymphoma trial: a phase II non-randomised
trial (FLUMIZ).
Lancet Oncol. 2008 Apr;9(4):352-8. Epub 2008 Mar 14. PubMed PMID:
18342572.
49: Piccaluga PP, Martinelli G, Isidori A, Malagola M, Rondoni M,
Paolini S,
Amabile M, Iacobucci I, Baccarani M, Visani G. Long-term molecular
complete
remission with IFN-alpha in Ph+ adult acute lymphoid leukemia
patients. Leukemia.
2008 Aug;22(8):1617-8. Epub 2008 Feb 14. PubMed PMID:
18273047.
50: Piccaluga PP, Malagola M, Rondoni M, Arpinati M, Paolini S,
Candoni A, Fanin
R, Messa E, Pirrotta MT, Lauria F, Visani G, Alberti D, Rancati F,
Vinaccia V,
Russo D, Saglio G, Baccarani M, Martinelli G. Imatinib mesylate in
the treatment
of newly diagnosed or refractory/resistant c-KIT positive acute
myeloid leukemia.
Results of an Italian Multicentric Phase II Study. Haematologica.
2007
Dec;92(12):1721-2. PubMed PMID: 18056005.
51: Piccaluga PP, Agostinelli C, Califano A, Carbone A, Fantoni L,
Ferrari S,
Gazzola A, Gloghini A, Righi S, Rossi M, Tagliafico E, Zinzani PL,
Zupo S,
Baccarani M, Pileri SA. Gene expression analysis of
angioimmunoblastic lymphoma
indicates derivation from T follicular helper cells and vascular
endothelial
growth factor deregulation. Cancer Res. 2007 Nov
15;67(22):10703-10. PubMed PMID:
18006812.
52: Piccaluga PP, Rondoni M, Paolini S, Rosti G, Martinelli G,
Baccarani M.
Imatinib mesylate in the treatment of hematologic malignancies.
Expert Opin Biol
Ther. 2007 Oct;7(10):1597-611. Review. PubMed PMID: 17916051.
53: Piccaluga PP, Paolini S, Martinelli G. Tyrosine kinase
inhibitors for the
treatment of Philadelphia chromosome-positive adult acute
lymphoblastic leukemia.
Cancer. 2007 Sep 15;110(6):1178-86. Review. PubMed PMID:
17701954.
54: Piccaluga PP, Finelli C, Vigna E, Agostinelli C, Bacci F,
Paolini S,
Papayannidis C, Laterza C, Martinelli G, Pileri SA, Baccarani M.
Paraplegia due
to a paravertebral extramedullary haemopoiesis in a patient with
polycythaemia
vera. J Clin Pathol. 2007 May;60(5):581-2. Erratum in: J Clin
Pathol. 2007
Jul;60(7):848. Padiai, Stefania [corrected to Paolini, Stefania].
PubMed PMID:
17513521; PubMed Central PMCID: PMC1994544.
55: Piccaluga PP, Agostinelli C, Righi S, Zinzani PL, Pileri SA.
Expression of
CD52 in peripheral T-cell lymphoma. Haematologica. 2007
Apr;92(4):566-7. PubMed
PMID: 17488672.
56: De Falco G, Leucci E, Lenze D, Piccaluga PP, Claudio PP, Onnis
A, Cerino G,
Nyagol J, Mwanda W, Bellan C, Hummel M, Pileri S, Tosi P, Stein H,
Giordano A,
Leoncini L. Gene-expression analysis identifies novel RBL2/p130
target genes in
endemic Burkitt lymphoma cell lines and primary tumors. Blood. 2007
Aug
15;110(4):1301-7. Epub 2007 May 7. PubMed PMID: 17485552.
57: Piccaluga PP, Ascani S, Agostinelli C, Paolini S, Laterza C,
Papayannidis C,
Martinelli G, Visani G, Baccarani M, Pileri SA. Myeloid sarcoma of
liver: an
unusual cause of jaundice. Report of three cases and review of
literature.
Histopathology. 2007 May;50(6):802-5. Epub 2007 Mar 13. Review.
PubMed PMID:
17355272.
58: Soverini S, Colarossi S, Gnani A, Castagnetti F, Rosti G, Bosi
C, Paolini S,
Rondoni M, Piccaluga PP, Palandri F, Giannoulia P, Marzocchi G,
Luatti S, Testoni
N, Iacobucci I, Cilloni D, Saglio G, Baccarani M, Martinelli G.
Resistance to
dasatinib in Philadelphia-positive leukemia patients and the
presence or the
selection of mutations at residues 315 and 317 in the BCR-ABL
kinase domain.
Haematologica. 2007 Mar;92(3):401-4. PubMed PMID: 17339191.
59: Piccaluga PP, Agostinelli C, Califano A, Rossi M, Basso K, Zupo
S, Went P,
Klein U, Zinzani PL, Baccarani M, Dalla Favera R, Pileri SA. Gene
expression
analysis of peripheral T cell lymphoma, unspecified, reveals
distinct profiles
and new potential therapeutic targets. J Clin Invest. 2007
Mar;117(3):823-34.
Epub 2007 Feb 15. PubMed PMID: 17304354; PubMed Central PMCID:
PMC1794115.
60: Malagola M, Damiani D, Martinelli G, Michelutti A, Cesana B,
Vivo AD,
Piccaluga PP, Ottaviani E, Candoni A, Geromin A, Tiribelli M, Fanin
R, Testoni N,
Lauria F, Bocchia M, Gobbi M, Pierri I, Zaccaria A, Zuffa E, Mazza
P, Priccolo G,
Gugliotta L, Bonini A, Visani G, Skert C, Bergonzi C, Roccaro AM,
Filí C,
Baccarani M, Russo D. Case-control study of multidrug resistance
phenotype and
response to induction treatment including or not fludarabine in
newly diagnosed
acute myeloid leukaemia patients. Br J Haematol. 2007
Jan;136(1):87-95. PubMed
PMID: 17222198.
61: Pileri SA, Ascani S, Cox MC, Campidelli C, Bacci F, Piccioli M,
Piccaluga PP,
Agostinelli C, Asioli S, Novero D, Bisceglia M, Ponzoni M, Gentile
A, Rinaldi P,
Franco V, Vincelli D, Pileri A Jr, Gasbarra R, Falini B, Zinzani
PL, Baccarani M.
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic
analysis of 92
adult patients. Leukemia. 2007 Feb;21(2):340-50. Epub 2006 Dec 14.
PubMed PMID:
17170724.
62: Visani G, Mele A, Guiducci B, D'Adamo F, Leopardi G, Barulli S,
Malerba L,
Lucesole M, Sparaventi G, Piccaluga PP, Guernaccini E, Agostinelli
F, Isidori A.
An observational study of once weekly intravenous ganciclovir as
CMV prophylaxis
in heavily pre-treated chronic lymphocytic leukemia patients
receiving
subcutaneous alemtuzumab. Leuk Lymphoma. 2006 Dec;47(12):2542-6.
PubMed PMID:
17169798.
63: Soverini S, Martinelli G, Colarossi S, Gnani A, Castagnetti F,
Rosti G, Bosi
C, Paolini S, Rondoni M, Piccaluga PP, Palandri F, Giannoulia P,
Marzocchi G,
Luatti S, Testoni N, Iacobucci I, Cilloni D, Saglio G, Baccarani M.
Presence or
the emergence of a F317L BCR-ABL mutation may be associated with
resistance to
dasatinib in Philadelphia chromosome-positive leukemia. J Clin
Oncol. 2006 Nov
20;24(33):e51-2. PubMed PMID: 17114651.
64: Piccaluga PP, Martinelli G, Rondoni M, Visani G, Baccarani M.
Advances and
potential treatment for Philadelphia chromosome-positive adult
acute lymphoid
leukaemia. Expert Opin Biol Ther. 2006 Oct;6(10):1011-22. Review.
PubMed PMID:
16989583.
65: Tagliafico E, Tenedini E, Manfredini R, Grande A, Ferrari F,
Roncaglia E,
Bicciato S, Zini R, Salati S, Bianchi E, Gemelli C, Montanari M,
Vignudelli T,
Zanocco-Marani T, Parenti S, Paolucci P, Martinelli G, Piccaluga
PP, Baccarani M,
Specchia G, Torelli U, Ferrari S. Identification of a molecular
signature
predictive of sensitivity to differentiation induction in acute
myeloid leukemia.
Leukemia. 2006 Oct;20(10):1751-8. Epub 2006 Aug 17. PubMed PMID:
16932344.
66: Piccaluga PP, Vigna E, Placci A, Agostinelli C, Laterza C,
Papayannidis C,
Leone O, Martinelli G, Zinzani PL, Baccarani M, Pileri SA. Primary
cardiac
non-Hodgkin lymphoma presenting with atrial flutter and pericardial
effusion. Br
J Haematol. 2006 Aug;134(4):356. PubMed PMID: 16882130.
67: Visani G, Olivieri A, Malagola M, Brunori M, Piccaluga PP,
Capelli D,
Pomponio G, Martinelli G, Isidori A, Sparaventi G, Leoni P.
Consolidation therapy
for adult acute myeloid leukemia: a systematic analysis according
to evidence
based medicine. Leuk Lymphoma. 2006 Jun;47(6):1091-102. PubMed
PMID: 16840201.
68: Went P, Agostinelli C, Gallamini A, Piccaluga PP, Ascani S,
Sabattini E,
Bacci F, Falini B, Motta T, Paulli M, Artusi T, Piccioli M, Zinzani
PL, Pileri
SA. Marker expression in peripheral T-cell lymphoma: a
proposed
clinical-pathologic prognostic score. J Clin Oncol. 2006 Jun
1;24(16):2472-9.
Epub 2006 Apr 24. PubMed PMID: 16636342.
69: Piccaluga PP, Martinelli G, Baccarani M. Advances in the
treatment for
haematological malignancies. Expert Opin Pharmacother. 2006
Apr;7(6):721-32.
Review. PubMed PMID: 16556088.
70: Piccaluga PP, Malagola M, Rondoni M, Ottaviani E, Testoni N,
Laterza C,
Visani G, Pileri SA, Martinelli G, Baccarani M. Poor outcome of
adult acute
lymphoblastic leukemia patients carrying the (1;19)(q23;p13)
translocation. Leuk
Lymphoma. 2006 Mar;47(3):469-72. PubMed PMID: 16396770.
71: Nyåkern M, Tazzari PL, Finelli C, Bosi C, Follo MY, Grafone T,
Piccaluga PP,
Martinelli G, Cocco L, Martelli AM. Frequent elevation of Akt
kinase
phosphorylation in blood marrow and peripheral blood mononuclear
cells from
high-risk myelodysplastic syndrome patients. Leukemia. 2006
Feb;20(2):230-8.
PubMed PMID: 16341040.
72: Russo D, Malagola M, de Vivo A, Fiacchini M, Martinelli G,
Piccaluga PP,
Damiani D, Candoni A, Michielutti A, Castelli M, Testoni N,
Ottaviani E, Rondoni
M, Pricolo G, Mazza P, Zuffa E, Zaccaria A, Raspadori D, Bocchia M,
Lauria F,
Bonini A, Avanzini P, Gugliotta L, Visani G, Fanin R, Baccarani M.
Multicentre
phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin
versus
idarubicin, Ara-C and etoposide for induction treatment of younger,
newly
diagnosed acute myeloid leukaemia patients. Br J Haematol. 2005
Oct;131(2):172-9.
Erratum in: Br J Haematol. 2006 Mar;132(6):804. PubMed PMID:
16197446.
73: van der Holt B, Löwenberg B, Burnett AK, Knauf WU, Shepherd J,
Piccaluga PP,
Ossenkoppele GJ, Verhoef GE, Ferrant A, Crump M, Selleslag D,
Theobald M, Fey MF,
Vellenga E, Dugan M, Sonneveld P. The value of the MDR1 reversal
agent PSC-833 in
addition to daunorubicin and cytarabine in the treatment of elderly
patients with
previously untreated acute myeloid leukemia (AML), in relation to
MDR1 status at
diagnosis. Blood. 2005 Oct 15;106(8):2646-54. Epub 2005 Jun 30.
PubMed PMID:
15994288.
74: Piccaluga PP, Agostinelli C, Zinzani PL, Baccarani M, Dalla
Favera R, Pileri
SA. Expression of platelet-derived growth factor receptor alpha in
peripheral
T-cell lymphoma not otherwise specified. Lancet Oncol. 2005
Jun;6(6):440. PubMed
PMID: 15925824.
75: Mele A, Leopardi G, Sparaventi G, Nicolini G, D'Adamo F,
Guiducci B, Barulli
S, Malerba L, Stramigioli S, Talevi N, Politi P, Isidori A,
Malagola M, Piccaluga
P, Visani G. Mini-ICE effectively mobilises peripheral blood stem
cells after
fludarabine-based regimens in acute myeloid leukaemia. Eur J
Haematol. 2005
Apr;74(4):277-81. PubMed PMID: 15777338.
76: Zinzani PL, Dirnhofer S, Sabattini E, Alinari L, Piccaluga PP,
Stefoni V,
Tani M, Musuraca G, Marchi E, Falini B, Baccarani M, Pileri SA.
Identification of
outcome predictors in diffuse large B-cell lymphoma.
Immunohistochemical
profiling of homogeneously treated de novo tumors with nodal
presentation on
tissue micro-arrays. Haematologica. 2005 Mar;90(3):341-7. PubMed
PMID: 15749666.
77: Pileri SA, Piccaluga PP, Sabattini E, Zinzani PL. The
development of more
than one histologic type of lymphoma in the same patient is
frequent and confers
a worse prognosis. Haematologica. 2005 Mar;90(3):293. PubMed PMID:
15749657.
78: Malagola M, Martinelli G, Rondoni M, Paolini S, Gaitani S,
Arpinati M,
Piccaluga PP, Amabile M, Basi C, Ottaviani E, Candoni A, Gottardi
E, Cilloni D,
Bocchia M, Saglio G, Lauria F, Fanin R, Visani G, Marrè MC, Maderna
M, Rancati F,
Vinaccia V, Russo D, Baccarani M. Imatinib mesylate in the
treatment of
c-kit-positive acute myeloid leukemia: is this the real target?
Blood. 2005 Jan
15;105(2):904; author reply 905. PubMed PMID: 15632213.
79: Visani G, Guiducci B, D'Adamo F, Mele A, Nicolini G, Leopardi
G, Sparaventi
G, Barulli S, Malerba L, Isidori A, Malagola M, Piccaluga PP.
Cyclophosphamide,
pegylated liposomal doxorubicin, vincristine and prednisone (CDOP)
plus rituximab
is effective and well tolerated in poor performance status elderly
patients with
non-Hodgkin's lymphoma. Leuk Lymphoma. 2005 Mar;46(3):477-9. PubMed
PMID:
15621843.
80: Piccaluga PP, Martinelli G, Malagola M, Rondoni M, Bonifazi F,
Bandini G,
Visani G, Baccarani M. Alemtuzumab in the treatment of relapsed
acute lymphoid
leukaemia. Leukemia. 2005 Jan;19(1):135; author reply 136. PubMed
PMID: 15510200.
81: Piccaluga PP, Malagola M, Amabile M, Rondoni M, Paolini S, Pane
F, Russo D,
Visani G, Baccarani M, Martinelli G. The achievement of molecular
complete
remission during treatment with imatinib mesylate correlates with
relapse-free
survival in bcr/abl-positive acute lymphoid leukemia patients.
Haematologica.
2004 Oct;89(10):1269-71. PubMed PMID: 15477218.
82: Visani G, Malagola M, Piccaluga PP, Isidori A. Low dose Ara-C
for
myelodysplastic syndromes: is it still a current therapy? Leuk
Lymphoma. 2004
Aug;45(8):1531-8. Review. PubMed PMID: 15370203.
83: Visani G, Isidori A, Grafone T, Tosi P, Santini V, Malagola M,
Martinelli G,
Piccaluga PP, Gaziev D, Ottaviani E, Sparaventi G, Tura S. No
preferential
sensitivity of t(8;21) acute myeloid leukemias to cytosine
arabinoside in vitro:
is intensity of therapy or high dose Ara-C crucial for response?
Leuk Lymphoma.
2004 Jul;45(7):1361-4. PubMed PMID: 15359633.
84: Malagola M, Martinelli G, Rondoni M, Ottaviani E, Piccaluga PP,
Ricci P,
Visani G, Baccarani M. Soft tissue and skeletal involvement in
FIP1L1-PDGFR-alpha
positive chronic eosinophilic leukemia: imatinib mesylate may
induce complete
molecular and imaging remission. Haematologica. 2004
Aug;89(8):ECR25. PubMed
PMID: 15339694.
85: Piccaluga PP, Martinelli G, Rondoni M, Malagola M, Gaitani S,
Visani G,
Baccarani M. First experience with gemtuzumab ozogamicin plus
cytarabine as
continuous infusion for elderly acute myeloid leukaemia patients.
Leuk Res. 2004
Sep;28(9):987-90. PubMed PMID: 15234577.
86: Piccaluga PP, Martinelli G, Rondoni M, Malagola M, Gaitani S,
Isidori A,
Bonini A, Gugliotta L, Luppi M, Morselli M, Sparaventi G, Visani G,
Baccarani M.
Gemtuzumab ozogamicin for relapsed and refractory acute myeloid
leukemia and
myeloid sarcomas. Leuk Lymphoma. 2004 Sep;45(9):1791-5. PubMed
PMID: 15223637.
87: Mele A, Sparaventi G, Guiducci B, Nicolini G, d'Adamo F,
Leopardi G, Delfini
C, Piccaluga P, Visani G. Gemtuzumab ozogamicin plus cytarabine
determines
complete remission in acute myeloid leukemia refractory to a double
conventional
treatment: a case report. Haematologica. 2004 Jun 1;89(6
Suppl):ECR18. PubMed
PMID: 15194554.
88: Piccaluga PP, Martinelli G, Malagola M, Rondoni M, Bianchini M,
Vigna E, Bosi
C, Gaitani S, Visani G, Baccarani M. Anti-leukemic and anti-GVHD
effects of
campath-1H in acute lymphoblastic leukemia relapsed after
stem-cell
transplantation. Leuk Lymphoma. 2004 Apr;45(4):731-3. PubMed PMID:
15160947.
89: Piccaluga PP, Ricci P, Martinelli G, Malagola M, Rondoni M,
Visani G. Prompt
resolution of nasal aspergillosis with intranasal instillation of
liposomal
amphotericin-B (amBisome) and granulocyte transfusions. Leuk
Lymphoma. 2004
Mar;45(3):637-8. PubMed PMID: 15160933.
90: Piccaluga PP, Luatti S, Ascani S, Bianchini M, Malagola M,
Rondoni M, Gaitani
S, Testoni N, Pileri SA, Baccarani M, Martinelli G, Visani G.
Identification of a
novel t(1;9)(q11;q34) in acute myelocytic leukemia. Cancer Genet
Cytogenet. 2004
May;151(1):85-6. PubMed PMID: 15120916.
91: Piccaluga PP, Malagola M, Rondoni M, Amabile M, Paolini S,
Soverini S,
Gaitani S, Visani G, Baccarani M, Martinelli G. Dose increase of
imatinib
mesylate may overcome acquired resistance in bcr/abl-positive acute
lymphoid
leukaemia. Eur J Haematol. 2004 Apr;72(4):302-3. PubMed PMID:
15089772.
92: Ascani S, Sabattini E, Agostinelli C, Piccaluga PP, Zinzani PL,
Pileri SA.
Erythrophagocytosis by neoplastic cells in a patient with
myelodysplastic
syndrome. Haematologica. 2004 Apr;89(4):EIM07. PubMed PMID:
15075110.
93: Martinelli G, Rondoni M, Buonamici S, Ottaviani E, Piccaluga
PP, Malagola M,
Baccarani M. Molecular monitoring to identify a threshold of
CBFbeta/MYH11
transcript below which continuous complete remission of acute
myeloid leukemia
inv16 is likely. Haematologica. 2004 Apr;89(4):495-7. PubMed PMID:
15075086.
94: Piccaluga PP, Poletti G, Martinelli G, Gherlinzoni F. Babesia
infection in
Italy. Lancet Infect Dis. 2004 Apr;4(4):212. PubMed PMID:
15050938.
95: Ascani S, Went P, Liberati AM, Piccaluga PP, Zinzani PL, Pileri
SA. Difficult
diagnostic and therapeutic cases: CASE 1. true thymic hyperplasia
in a patient
treated for T-cell lymphoma. J Clin Oncol. 2004 Mar 1;22(5):953-4.
PubMed PMID:
14990652.
96: Piccaluga PP, Martinelli G, Rondoni M, Malagola M, Ronconi S,
Visani G,
Baccarani M. Low dose gemtuzumab ozogamicin for relapsed acute
myeloid leukaemia
in elderly. Haematologica. 2003 Dec;88(12):ECR37. PubMed PMID:
14688010.
97: Martinelli G, Ottaviani E, Buonamici S, Isidori A, Borsaru G,
Visani G,
Piccaluga PP, Malagola M, Testoni N, Rondoni M, Nucifora G, Tura S,
Baccarani M.
Association of 3q21q26 syndrome with different RPN1/EVI1 fusion
transcripts.
Haematologica. 2003 Nov;88(11):1221-8. PubMed PMID: 14607750.
98: Piccaluga PP, Bianchini M, Martinelli G. Novel FLT3 point
mutation in acute
myeloid leukaemia. Lancet Oncol. 2003 Oct;4(10):604. PubMed PMID:
14554237.
99: Bianchini M, Ottaviani E, Grafone T, Giannini B, Soverini S,
Terragna C,
Amabile M, Piccaluga PP, Malagola M, Rondoni M, Bosi C, Baccarani
M, Martinelli
G. Rapid detection of Flt3 mutations in acute myeloid leukemia
patients by
denaturing HPLC. Clin Chem. 2003 Oct;49(10):1642-50. PubMed PMID:
14500589.
100: Herwaldt BL, Cacciò S, Gherlinzoni F, Aspöck H, Slemenda SB,
Piccaluga P,
Martinelli G, Edelhofer R, Hollenstein U, Poletti G, Pampiglione S,
Löschenberger
K, Tura S, Pieniazek NJ. Molecular characterization of a
non-Babesia divergens
organism causing zoonotic babesiosis in Europe. Emerg Infect Dis.
2003
Aug;9(8):942-8. PubMed PMID: 12967491.
101: Piccaluga PP, Martinelli G, Malagola M, Rondoni M, Bianchini
M, Visani G,
Baccarani M. Complete remission in acute myeloid leukemia with
granulocyte-colony
stimulating factor without chemotherapy. Report of cytogenetic
remission of a
t(9;11)(p22q23) positive AML patient and review of literature.
Haematologica.
2003 Aug;88(8):ECR28. Review. PubMed PMID: 12935987.
102: Visani G, Mele A, Malagola M, Isidori A, Finelli C, Piccaluga
PP. Sequential
combination of thalidomide and erythropoietin determines
transfusion independence
and disease control in idiopathic myelofibrosis previously
insensitive to both
drugs used as single agents. Leukemia. 2003 Aug;17(8):1669-70.
PubMed PMID:
12886259.
103: Ascani S, Piccaluga PP, Pileri SA. Granulocytic sarcoma of
main biliary
ducts. Br J Haematol. 2003 May;121(4):534. PubMed PMID:
12752094.
104: Piccaluga PP, Visani G, Isidori A, Malagola M, Ascani S,
Pileri SA.
Microdose alpha-interferon shows clinical and antiangiogenic effect
in
extramedullary myeloid tumor: a case report. Leukemia. 2003
May;17(5):986-7.
PubMed PMID: 12750719.
105: Visani G, Piccaluga PP, Martinelli G, Rossi M, Malagola M,
Baccarani M.
Sustained molecular remission in advanced acute promyelocytic
leukemia with
combined pulsed retinoic acid and arsenic trioxide. Clinical
evidence of
synergistic effect and real-time quantification of minimal residual
disease.
Haematologica. 2003 Apr;88(4):ELT15. PubMed PMID: 12681992.
106: Martinelli G, Buonamici S, Visani G, Malagola M, Piccaluga PP,
Isidori A,
Bosi C, Bonifazi F, Soverini S, Terragna C, Amabile M, Giannini B,
Baccarani M.
Molecular monitoring of acute myeloid leukemia associated with
inv(16): threshold
of CBFbeta/MYH11 transcript copy number above which relapse occurs
and below
which continuous Complete Remission is likely. Leukemia. 2003
Mar;17(3):650-1;
author reply 651-2. PubMed PMID: 12646962.
107: Barosi G, Elliott M, Canepa L, Ballerini F, Piccaluga PP,
Visani G,
Marchetti M, Pozzato G, Zorat F, Tefferi A. Thalidomide in
myelofibrosis with
myeloid metaplasia: a pooled-analysis of individual patient data
from five
studies. Leuk Lymphoma. 2002 Dec;43(12):2301-7. Erratum in: Leuk
Lymphoma. 2009
Dec;50(12):2102. Giovanni, Barosi [corrected to Barosi, Giovanni];
Michelle,
Elliott [corrected to Elliott, Michelle]; Letizia, Canepa
[corrected to Canepa,
Letizia]; Filippo, Ballerini [corrected to Ballerini, Filippo];
Pier Paolo,
Piccaluga [corrected to Piccaluga, Pier Paolo]; Giuseppe, Visani
[corrected to
Visani, Giuseppe]; Monia, Marchetti [corrected to Marchetti,
Monia]; Gabriele,
Pozzato [corrected to Pozzato, Gabriele]; Francesca, Zorat
[corrected to Zorat,
Francesca]; Ayalew, Tefferi [corrected to Tefferi, Ayalew]. PubMed
PMID:
12613516.
108: Pagano L, Mele L, Fianchi L, Rutella S, Piscitelli R, Leone G,
Pulsoni A, De
Fabritiis P, Foà R, Mandelli F, Visani G, Piccaluga P, Di Bona E,
Cerri R, Risso
M, Tosti ME, Venditti A; GIMEMA Study Group on Secondary
Leukemias.
Immunophenotypic analysis in 119 patients with acute myeloid
leukemia following a
previous malignancy: a comparison with the immunophenotype of 231
de novo AML.
Haematologica. 2003 Feb;88(2):225-7. PubMed PMID: 12604416.
109: Martinelli G, Piccaluga PP, Lo Coco F. FLT3 inhibition as
tailored therapy
for acute myeloid leukemia. Haematologica. 2003 Jan;88(1):4-8.
PubMed PMID:
12551818.
110: Pileri SA, Gaidano G, Zinzani PL, Falini B, Gaulard P, Zucca
E, Pieri F,
Berra E, Sabattini E, Ascani S, Piccioli M, Johnson PW, Giardini R,
Pescarmona E,
Novero D, Piccaluga PP, Marafioti T, Alonso MA, Cavalli F. Primary
mediastinal
B-cell lymphoma: high frequency of BCL-6 mutations and consistent
expression of
the transcription factors OCT-2, BOB.1, and PU.1 in the absence
of
immunoglobulins. Am J Pathol. 2003 Jan;162(1):243-53. PubMed PMID:
12507907;
PubMed Central PMCID: PMC1851125.
111: Pileri SA, Ascani S, Zinzani PL, Gaidano G, Piccioli M, Rossi
M, Piccaluga
PP, Marafioti T, Pileri A Jr, Pacini R, Falini B, Sabattini E.
Diffuse large
B-cell lymphoma (DLBCL), anaplastic variant. report on a
problematic case
primarily arising in the stomach. Haematologica. 2002
Dec;87(12):ECR40. PubMed
PMID: 12495911.
112: Visani G, Isidori A, Malagola M, Alberti D, Capdeville R,
Martinelli G,
Piccaluga PP, Amabile M, Guiducci B, Tura S, Baccarani M. Efficacy
of imatinib
mesylate (STI571) in conjunction with alpha-interferon: long-term
quantitative
molecular remission in relapsed P-190(BCR-ABL)-positive acute
lymphoblastic
leukemia. Leukemia. 2002 Oct;16(10):2159-60. PubMed PMID:
12357372.
113: Russo D, Piccaluga PP, Michieli M, Michelutti T, Visani G,
Gugliotta L,
Bonini A, Pierri I, Gobbi M, Tiribelli M, Fanin R, Piccolrovazzi S,
Baccarani M.
Liposomal daunorubicin (DaunoXome) for treatment of poor-risk acute
leukemia. Ann
Hematol. 2002 Aug;81(8):462-6. Epub 2002 Aug 27. PubMed PMID:
12224004.
114: Piccaluga PP, Visani G, Martinelli G, Isidori A, Malagola M,
Rondoni M,
Baccarani M, Tura S. Liposomal daunorubicin (DaunoXome) for
treatment of relapsed
meningeal acute myeloid leukemia. Leukemia. 2002 Sep;16(9):1880-1.
PubMed PMID:
12200714.
115: Piccaluga PP, Visani G, Pileri SA, Ascani S, Grafone T,
Isidori A, Malagola
M, Finelli C, Martinelli G, Ricci P, Baccarani M, Tura S. Clinical
efficacy and
antiangiogenic activity of thalidomide in myelofibrosis with
myeloid metaplasia.
A pilot study. Leukemia. 2002 Sep;16(9):1609-14. PubMed PMID:
12200671.
116: Zinzani PL, Tani M, Stefoni V, Piccaluga PP, Baccarani M,
Ascani S, Pileri
S. From chronic lymphocytic leukemia to Hodgkin's disease: a case
of
prognostically favorable transformation. Leuk Res. 2002
Aug;26(8):775-6. PubMed
PMID: 12191574.
117: Martinelli G, Ottaviani E, Buonamici S, Isidori A, Malagola M,
Piccaluga P,
Baccarani M. Two more inv(16) acute myeloid leukemia cases with
infrequent
CBFbeta-MYH11 fusion transcript: clinical and molecular findings.
Haematologica.
2002 May;87(5):554-5. PubMed PMID: 12010674.
118: Pagano L, Fianchi L, Mele L, Girmenia C, Offidani M, Ricci P,
Mitra ME,
Picardi M, Caramatti C, Piccaluga P, Nosari A, Buelli M, Allione B,
Cortelezzi A,
Fabbiano F, Milone G, Invernizzi R, Martino B, Masini L, Todeschini
G, Cappucci
MA, Russo D, Corvatta L, Martino P, Del Favero A. Pneumocystis
carinii pneumonia
in patients with malignant haematological diseases: 10 years'
experience of
infection in GIMEMA centres. Br J Haematol. 2002 May;117(2):379-86.
PubMed PMID:
11972521.
119: Pileri SA, Ascani S, Leoncini L, Sabattini E, Zinzani PL,
Piccaluga PP,
Pileri A Jr, Giunti M, Falini B, Bolis GB, Stein H. Hodgkin's
lymphoma: the
pathologist's viewpoint. J Clin Pathol. 2002 Mar;55(3):162-76.
Review. PubMed
PMID: 11896065; PubMed Central PMCID: PMC1769601.
120: Piccaluga PP, Visani G, Finelli C, Grafone T, Baccarani M,
Tura S. Efficacy
of thalidomide in the treatment of myelodysplastic syndromes.
Haematologica. 2002
Mar;87(3):ELT18. PubMed PMID: 11869964.
121: Buonamici S, Ottaviani E, Testoni N, Montefusco V, Visani G,
Bonifazi F,
Amabile M, Terragna C, Ruggeri D, Piccaluga PP, Isidori A, Malagola
M, Baccarani
M, Tura S, Martinelli G. Real-time quantitation of minimal residual
disease in
inv(16)-positive acute myeloid leukemia may indicate risk for
clinical relapse
and may identify patients in a curable state. Blood. 2002 Jan
15;99(2):443-9.
PubMed PMID: 11781223.
122: Pileri SA, Zinzani PL, Ascani S, Orcioni GF, Gamberi B,
Piccioli M,
Sabattini E, Poggi S, Piccaluga PP, Falini B. Diffuse large B-cell
lymphoma with
primary retroperitoneal presentation: clinico-pathologic study of
nine cases. Ann
Oncol. 2001 Oct;12(10):1445-53. PubMed PMID: 11762818.
123: Visani G, Buonamici S, Malagola M, Isidori A, Piccaluga PP,
Martinelli G,
Ottaviani E, Grafone T, Baccarani M, Tura S. Pulsed ATRA as single
therapy
restores long-term remission in PML-RARalpha-positive acute
promyelocytic
leukemia patients: real time quantification of minimal residual
disease. A pilot
study. Leukemia. 2001 Nov;15(11):1696-700. PubMed PMID:
11681409.
124: Pileri SA, Facchetti F, Ascani S, Sabattini E, Poggi S,
Piccioli M, Rondelli
D, Vergoni F, Zinzani PL, Piccaluga PP, Falini B, Isaacson PG.
Myeloperoxidase
expression by histiocytes in Kikuchi's and Kikuchi-like
lymphadenopathy. Am J
Pathol. 2001 Sep;159(3):915-24. PubMed PMID: 11549584; PubMed
Central PMCID:
PMC1850446.
125: Visani G, Lemoli RM, Isidori A, Piccaluga PP, Martinelli G,
Malagola M,
Gugliotta L, Bonini A, Bonifazi F, Motta MR, Rizzi S, Castellani S,
Tura S.
Double reinforcement with fludarabine/high-dose cytarabine enhances
the impact of
autologous stem cell transplantation in acute myeloid leukemia
patients. Bone
Marrow Transplant. 2001 Apr;27(8):829-35. PubMed PMID:
11477440.
126: Visani G, Bernasconi P, Boni M, Castoldi GL, Ciolli S, Clavio
M, Cox MC,
Cuneo A, Del Poeta G, Dini D, Falzetti D, Fanin R, Gobbi M, Isidori
A, Leoni F,
Liso V, Malagola M, Martinelli G, Mecucci C, Piccaluga PP, Petti
MC, Rondelli R,
Russo D, Sessarego M, Specchia G, Testoni N, Torelli G, Mandelli F,
Tura S. The
prognostic value of cytogenetics is reinforced by the kind of
induction/consolidation therapy in influencing the outcome of acute
myeloid
leukemia--analysis of 848 patients. Leukemia. 2001 Jun;15(6):903-9.
Review.
PubMed PMID: 11417475.
127: Visani G, Milligan D, Leoni F, Chang J, Kelsey S, Marcus R,
Powles R, Schey
S, Covelli A, Isidori A, Litchman M, Piccaluga PP, Mayer H,
Malagola M, Pfister
C. Combined action of PSC 833 (Valspodar), a novel MDR reversing
agent, with
mitoxantrone, etoposide and cytarabine in poor-prognosis acute
myeloid leukemia.
Leukemia. 2001 May;15(5):764-71. PubMed PMID: 11368437.
128: Pileri SA, Ascani S, Sabattini E, Fraternali-Orcioni G, Poggi
S, Piccioli M,
Piccaluga PP, Gamberi B, Zinzani PL, Leoncini L, Falini B. The
pathologist's view
point. Part II --aggressive lymphomas. Haematologica. 2000
Dec;85(12):1308-21.
Review. PubMed PMID: 11114138.
129: Pileri SA, Ascani S, Sabattini E, Fraternali-Orcioni G, Poggi
S, Piccioli M,
Piccaluga PP, Gamberi B, Zinzani PL, Leoncini L, Falini B. The
pathologist's view
point. Part I--indolent lymphomas. Haematologica. 2000
Dec;85(12):1291-307.
Review. PubMed PMID: 11114137.
130: Zinzani PL, Ascani S, Piccaluga PP, Bendandi M, Pileri S, Tura
S. Efficacy
of rituximab in hairy cell leukemia treatment. J Clin Oncol. 2000
Nov
15;18(22):3875-7. PubMed PMID: 11078503.
131: Visani G, Pagano L, Pulsoni A, Tosi P, Piccaluga PP, Pastano
R, Grafone T,
Malagola M, Isidori A, Tura S. Chemotherapy of secondary leukemias.
Leuk
Lymphoma. 2000 May;37(5-6):543-9. Review. PubMed PMID:
11042514.
132: Visani G, Gugliotta L, Tosi P, Catani L, Vianelli N,
Martinelli G, Ottaviani
E, Testoni N, Nocentini F, Pastano R, Piccaluga P, Isidori A,
Grafone T, Tura S.
All-trans retinoic acid significantly reduces the incidence of
early hemorrhagic
death during induction therapy of acute promyelocytic leukemia. Eur
J Haematol.
2000 Mar;64(3):139-44. PubMed PMID: 10997878.
133: Piccaluga PP, Ascani S, Fraternali Orcioni G, Piccioli M,
Pileri Jr A,
Falini B, Pileri S. Anaplastic lymphoma kinase expression as a
marker of
malignancy. Application to a case of anaplastic large cell lymphoma
with huge
granulomatous reaction. Haematologica. 2000 Sep;85(9):978-81.
PubMed PMID:
10980638.
134: Zinzani PL, Bendandi M, Stefoni V, Albertini P, Gherlinzoni F,
Tani M,
Piccaluga PP, Tura S. Value of gemcitabine treatment in heavily
pretreated
Hodgkin's disease patients. Haematologica. 2000 Sep;85(9):926-9.
PubMed PMID:
10980630.
135: Visani G, Rosti G, Bandini G, Tosi P, Isidori A, Malagola M,
Stanzani M,
Martinelli G, Piccaluga P, Testoni N, Ricci P, Tura S. Second
chronic phase
before transplantation is crucial for improving survival of blastic
phase chronic
myeloid leukaemia. Br J Haematol. 2000 Jun;109(4):722-8. PubMed
PMID: 10929021.
136: Pileri SA, Fraternali-Orcioni G, Ascani S, Piccioli M, Poggi
S, Piccaluga
PP, Leoncini L, Falini B. [Aggressive lymphomas: a convenient
concept or an
anatomo-pathological reality?]. Pathologica. 2000 Jun;92(3):145-61.
Review.
Italian. PubMed PMID: 10902425.
137: Visani G, Martinelli G, Piccaluga P, Tosi P, Amabile M,
Pastano R, Cavo M,
Isidori A, Tura S. Alpha-interferon improves survival and remission
duration in
P-190BCR-ABL positive adult acute lymphoblastic leukemia. Leukemia.
2000
Jan;14(1):22-7. PubMed PMID: 10637472.
138: Visani G, Lemoli R, Tosi P, Martinelli G, Testoni N, Ricci P,
Motta M,
Gherlinzoni F, Leopardi G, Pastano R, Rizzi S, Piccaluga P, Isidori
A, Tura S.
Use of peripheral blood stem cells for autologous transplantation
in acute
myeloid leukemia patients allows faster engraftment and equivalent
disease-free
survival compared with bone marrow cells. Bone Marrow Transplant.
1999
Sep;24(5):467-72. PubMed PMID: 10482929.
139: Visani G, Lemoli RM, Tosi P, Martinelli G, Testoni N, Ricci P,
Piccaluga PP,
Pastano R, Leopardi G, Dizdari A, Motta MR, Rizzi S, Tura S.
Fludarabine-containing regimens severely impair peripheral blood
stem cells
mobilization and collection in acute myeloid leukaemia patients. Br
J Haematol.
1999 Jun;105(3):775-9. PubMed PMID: 10354146.
140: Pileri SA, Roncador G, Ceccarelli C, Piccioli M, Sabattini E,
Briskomatis A,
Santini D, Leone O, Piccaluga PP, Leoncini L, Falini B.
Immunohistochemistry of
bone-marrow biopsy. Leuk Lymphoma. 1997 Dec;26 Suppl 1:69-75.
PubMed PMID:
9570682.
141: Ascani S, Piccioli M, Poggi S, Briskomatis A, Bolis GB,
Liberati F,
Frongillo R, Caramatti C, Fraternali-Orcioni G, Gamberi B, Zinzani
PL, Lazzi S,
Leoncini L, O'Leary J, Piccaluga PP, Pileri SA.
Pyothorax-associated lymphoma:
description of the first two cases detected in Italy. Ann Oncol.
1997
Nov;8(11):1133-8. PubMed PMID: 9426333.
142: Pileri SA, Roncador G, Ceccarelli C, Piccioli M, Briskomatis
A, Sabattini E,
Ascani S, Santini D, Piccaluga PP, Leone O, Damiani S, Ercolessi C,
Sandri F,
Pieri F, Leoncini L, Falini B. Antigen retrieval techniques
in
immunohistochemistry: comparison of different methods. J Pathol.
1997
Sep;183(1):116-23. PubMed PMID: 9370957.
143: Ascani S, Zinzani PL, Gherlinzoni F, Sabattini E, Briskomatis
A, de Vivo A,
Piccioli M, Fraternali Orcioni G, Pieri F, Goldoni A, Piccaluga PP,
Zallocco D,
Burnelli R, Leoncini L, Falini B, Tura S, Pileri SA. Peripheral
T-cell lymphomas.
Clinico-pathologic study of 168 cases diagnosed according to the
R.E.A.L.
Classification. Ann Oncol. 1997 Jun;8(6):583-92. PubMed PMID:
9261528.
144: Pileri SA, Pulford K, Mori S, Mason DY, Sabattini E, Roncador
G, Piccioli M,
Ceccarelli C, Piccaluga PP, Santini D, Leone O, Stein H, Falini B.
Frequent
expression of the NPM-ALK chimeric fusion protein in anaplastic
large-cell
lymphoma, lympho-histiocytic type. Am J Pathol. 1997
Apr;150(4):1207-11. PubMed
PMID: 9094977; PubMed Central PMCID: PMC1858171.
145: Pileri SA, Piccaluga A, Poggi S, Sabattini E, Piccaluga PP, De
Vivo A,
Falini B, Stein H. Anaplastic large cell lymphoma: update of
findings. Leuk
Lymphoma. 1995 Jun;18(1-2):17-25. Review. PubMed PMID:
8580821.
146: Pileri S, Piccaluga PP, De Vivo A, Sabattini E, Poggi S,
Melilli G, Falini
B, Piccaluga A. Malignant lymphomas of the gastro-intestinal tract:
a reappraisal
on the basis of the newly proposed Revised European American
Lymphoma
Classification. Ital J Gastroenterol. 1994 Oct-Nov;26(8):405-18.
Review. PubMed
PMID: 7703515.
Altre pubblicazioni
1. Martinelli G, Piccaluga PP,
Malagola M, Soverini S, Rondoni M, Isidori A, Bonifazi F, Giannini
B, Grafone T, Ottaviani E, De Vivo A, Bosi C, Bianchini M, Terragna
C, Fiacchini M, Ricci P, Visani G, Russo D, Bassi S, Trabacchi E,
Rosti G, Buonamici S, Alberti D, Baccarani M. Other targets for
Imatinib therapy. Journal on Biotechnology and Molecular Biology
15(1): 64, 2003.
2. Piccaluga PP, Ricci P,
Malagola M, Rondoni M, Vigna E, Bosi C, Gaitani S, Visani G,
Martinelli G. Instillazione diretta intranasale di amfotericina B
liposomiale nella terapia delle micosi nasali. Farmaci,
27(3): 13-15, 2004.
3. Vigna E, Placci A, Laterza C,
Agostinelli C, Papayannidis C, Martinelli G, Pileri SA, Piccaluga
PP. Impiego del pegfilgrastim in associazione cn R-CHOP in un
paziente critico affetto da un linfoma non Hodgkin aggressivo
primitivo del cuore. Continuing Education in Oncologia, Vol. II:3,
5-7, 2005.
4. Piccaluga PP, Vigna E,
Martinelli G. Fattibilità ed efficacia del regime chemioterapico
My-Flaig (mylotarg, fludarabina, citosina arabinsoide, idarubicina
e pegfilgrastim) nella terapia della leucemia acuta mieloide.
Continuing Education in Oncologia, Vol. II:3, 8-11, 2005.
5. Piccaluga PP. Leucemia
mieloide acuta: razionale e risultati clinici della terapia di
salvataggio. Update in Ematologia 2002, Vol. 1: 3-4.
6. Malagola M, Isidori A, Rondoni
M, Piccaluga PP, Martinelli G. Leucemia linfoblastica acuta:
identificazione del rischio. Update in Ematologia 2002, Vol. 1:
4-6.
7. Isidori A, Malagola M,
Piccaluga PP, Rondoni M, Martinelli G. Leucemia mieloide acuta:
ruolo dei regimi di induzione-consolidamento intensificati in
funzione del cariotipo. Update in Ematologia2002, Vol. 1: 8-10.
8. Coature del libro “Corso di
Malattie del Sangue e degli Organi Emopoietici”, Ed Esculapio,
Bologna, 2007.
9. Pileri, S.A., Agostinelli, C.,
Campidelli, C., Bacci, F., Sabattini, E., Giunti, M., Pileri, A.
Jr., Piccioli, M., Righi, S., Rossi, M., Ferri, C., and Piccaluga,
P.P.: Chronic inflammation, includine Autoimmunity, and
Lymphomagenesis. The lymphoid neoplasms, 3rd Edition. Ian Magrath,
Editor. Hodder Headline Group, London. In press.
10. Coature del libro “Corso di Malattie del Sangue e degli
Organi Emopoietici”, Ed Esculapio, Bologna, 2007.
11. Coautore del libro "Recommendation of the European Working
Group for Adult ALL" , Uni-Med Verlag AG, Bremen, 2011.